Search Results - "Rakhmanova, Zhemal"

Conversion from calcineurin inhibitors to sirolimus in transplant‐associated thrombotic microangiopathy by Kanunnikov, Mikhail M., Rakhmanova, Zhemal Z., Levkovsky, Nikita V., Vafina, Aliya I., Goloshapov, Oleg V., Shchegoleva, Tatiana S., Vlasova, Julia J., Paina, Olesya V., Morozova, Elena V., Zubarovskaya, Ludmilla, Kulagin, Alexander D., Moiseev, Ivan

“…Transplant‐associated thrombotic microangiopathy (TA‐TMA) is a specific complication of allogeneic hematopoietic cell transplantation with a multifactorial…”
Get full text

Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease by Kozlov, Andrey, Estrina, Maria, Paina, Olesia, Bykova, Tatiana, Osipova, Anna, Kozhokar, Polina, Rakhmanova, Zhemal, Solodova, Irina, Morozova, Elena, Alyansky, Alexander, Kulagina, Irina, Gevorgian, Asmik, Dotsenko, Anna, Moiseev, Ivan, Chukhlovin, Alexey, Kulagin, Alexander, Bondarenko, Sergey, Semenova, Elena, Zubarovskaya, Ludmila

“…Chronic graft versus host disease (cGVHD) remains a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). It significantly…”
Get full text

Early Hematopoietic Stem Cell Transplantation in the Treatment of High-Risk Infant Leukemia by Paina, Olesia V, Rakhmanova, Zhemal Zarifovna, Kozhokar, Polina Valerievna, Frolova, Anastasia Sergeevna, Tsvetkova, Luibov Alexandrovna, Borovkova, Anastasia Svyatoslavovna, Ekushov, Kirill Alexandrovich, Markova, Inna Viktorovna, Bondarenko, Sergey N., Babenko, Elena V, Alyanski, Aleksandr L., Barkhatov, Ildar M., Semenova, Elena Vladimirovna, Bakin, Eugene A., Kulagin, Aleksandr D., Moiseev, Ivan S., Zubarovskaya, Ludmila S

“…Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) are rare diseases in children less than one and two years old respectively. Infant ALL and…”
Get full text

Post‐transplant сyclophosphamide after matched donor hematopoietic stem cell transplantation in children with acute leukemia by Borovkova, Anastasya Svyatoslavovna, Paina, Olesya Vladimirovna, Semenova, Elena Vladimirovna, Bykova, Tatiana Alexandrovna, Osipova, Anna Alekseevna, Slesarchuk, Olga Alexandrovna, Kozhokar, Polina Valerievna, Tsvetkova, Lubov Alexandrovna, Rakhmanova, Zhemal Zarifovna, Kozlov, Andrei Vadimovich, Chukhlovin, Alexei Borisovich, Kazantsev, Ilya Viktorovich, Estrina, Maria Arkadievna, Goloshchapov, Oleg Valerievich, Bondarenko, Sergei Nikolaevich, Moiseev, Ivan Sergeevich, Kulagin, Alexander Dmitrievich, Zubarovskaya, Ludmila Stepanovna

“…Introduction The data on post‐transplant cyclophosphamide (PTCy) in pediatric acute leukemia after matched allo‐HSCT are limited to case series. The present…”
Get full text

Factors Affecting Post-Transplant Relapse of Acute Lymphoblastic Leukemia (ALL) in Children According on the Intensity of Conditioning by Semenova, Elena Vladimirovna, Kozhokar, Polina Valerievna, Paina, Olesia V, Rakhmanova, Zhemal Zarifovna, Frolova, Anastasia S, Tsvetkova, Luibov, Ekushov, Kirill Alexandrovich, Bykova, Tatiana A, Osipova, Anna A., Markova, Inna, Bondarenko, Sergey N., Smirnov, Boris I, Barkhatov, Ildar M, Gindina, Tatyana L., Moiseev, Ivan S., Zander, Axel R., Zubarovskaya, Ludmila S

“…Background: Relapse of ALL remains the major cause of transplant failure. Relapse incidence after allo-HSCT is described in 30-40% of patients. Patients with…”
Get full text

Risk Factors for Overall Survival in Children with High Risk Acute Myeloid Leukemia (HR AML) after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) with Different Intensity of Conditioning Regimens by Semenova, Elena Vladimirovna, Paina, Olesia V, Rakhmanova, Zhemal Zarifovna, Kozhokar, Polina Valerievna, Frolova, Anastasia S, Ekushov, Kirill Alexandrovich, Bykova, Tatiana A, Osipova, Anna A., Markova, Inna, Bondarenko, Sergey N., Smirnov, Boris I, Barkhatov, Ildar M, Alyanski, Aleksandr, Babenko, Elena V., Moiseev, Ivan S., Zander, Axel R., Zubarovskaya, Ludmila S

“…Background: Traditionally, children with AML undergo аllo-HSCT with myeloablative conditioning (MAC). It is known that MAC is associated with significant…”
Get full text

Comparison of FLU-BU12 Conditioning with the Standard BU-CY Myeloablative Regimen in High-Risk Pediatric ACUTE Myeloid Leukemia Patients Undergoing Allogeneic STEM Cell Transplantation by Paina, Olesia V, Rakhmanova, Zhemal Zarifovna, Kozhokar, Polina Valerievna, Frolova, Anastasia S, Tsvetkova, Liubov A., Ekushov, Kirill Alexandrovich, Markova, Inna, Bondarenko, Sergey N., Babenko, Elena V., Alyanskiy, Aleksandr L., Barkhatov, Ildar M, Semenova, Elena Vladimirovna, Kulagin, Aleksandr D., Moiseev, Ivan S., Zubarovskaya, Ludmila S

“…INTRODUCTION: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative therapy for high-risk acute myeloid leukemia (AML).The…”
Get full text

Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) with Different Intensity Conditioning Regimens in Children with Very High Risk Acute Lymphoblastic Leukemia (VHR ALL): A Single-Center Experience by Semenova, Elena Vladimirovna, Paina, Olesia V, Rakhmanova, Zhemal Zarifovna, Kozhokar, Polina Valerievna, Frolova, Anastasia S, Ekushov, Kirill Alexandrovich, Bykova, Tatiana A, Osipova, Anna, Markova, Inna V, Bondarenko, Sergey N., Barhatov, Ildar, Alyanski, Aleksandr, Babenko, Elena, Moiseev, Ivan S, Zubarovskaya, Ludmila S, Zander, Axel, Afanasyev, Boris V

“…Background: Allo-HSCT with myeloablative conditioning (MAC) has traditionally been performed in patients with ALL and has been associated with significant…”
Get full text

Comparison of Allogeneic Transplant Outcomes Using Conditioning with Different Dose of Busulfan for Children with Acute Myeloid Leukemia by Paina, Olesia V, Rakhmanova, Zhemal Zarifovna, Kozhokar, Polina Valerievna, Frolova, Anastasia S, Ekushov, Kirill Alexandrovich, Tsvetkova, Luibov, Bykova, Tatiana A, Markova, Inna V, Bondarenko, Sergey N., Barkhatov, Ildar M, Alyanski, Aleksandr, Babenko, Elena, Moiseev, Ivan S, Popova, Marina O, Semenova, Elena Vladimirovna, Zubarovskaya, Ludmila S, Zander, Axel, Afanasyev, Boris

“…Background. Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative therapy for patients with acute myeloid leukemia (AML). The…”
Get full text